Loading...
DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats
Diabetic cardiomyopathy (DCM) is a form of idiopathic heart disease, with signs including hypertrophy of myocardial cells, hypertension-independent fibrosis and coronary artery disease. Considering the involvement of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in diabetes, it was hypothesized...
Na minha lista:
| Udgivet i: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6317674/ https://ncbi.nlm.nih.gov/pubmed/30569164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.4034 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|